chr18-78980319-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_171999.4(SALL3):āc.45C>Gā(p.Asp15Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000368 in 1,439,074 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_171999.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SALL3 | NM_171999.4 | c.45C>G | p.Asp15Glu | missense_variant | 1/3 | ENST00000537592.7 | NP_741996.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SALL3 | ENST00000537592.7 | c.45C>G | p.Asp15Glu | missense_variant | 1/3 | 5 | NM_171999.4 | ENSP00000441823 | P1 | |
SALL3 | ENST00000575389.6 | c.45C>G | p.Asp15Glu | missense_variant | 1/4 | 5 | ENSP00000458360 |
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151320Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000245 AC: 21AN: 85754Hom.: 0 AF XY: 0.000268 AC XY: 13AN XY: 48500
GnomAD4 exome AF: 0.0000404 AC: 52AN: 1287754Hom.: 1 Cov.: 30 AF XY: 0.0000567 AC XY: 36AN XY: 634668
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151320Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 73916
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.45C>G (p.D15E) alteration is located in exon 1 (coding exon 1) of the SALL3 gene. This alteration results from a C to G substitution at nucleotide position 45, causing the aspartic acid (D) at amino acid position 15 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at